Oqory to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Powered by a proprietary ADC platform, Oqory is focused on delivering therapies that improve outcomes for patients with ...
Why is there an increase in lung cancer among women who have never smoked?
Rising air pollution, changes in hormone levels, immune system imbalances and longer life expectancy are increasing the risk ...
clinicaltrialsarena8h
Boehringer seeks approval of lung disease drug after second Phase III success
Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
Science Daily11h
Research pinpoints weakness in lung cancer's defenses
Scientists uncover an enzyme that boosts cancer cell metabolism to fuel growth. The enzyme, GUK1, supports metabolism in cancer cells to help tumors grow.
hospitalhealthcare16h
Lung cancer pathway insights from Dr Zaheer Mangera part 2: neoadjuvant therapy
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.